Harvard Bioscience
Harvard Bioscience is a global developer and manufacturer of specialized life science instruments for preclinical research, serving academic institutions, pharmaceutical companies, biotechnology firms, CROs, and government laboratories across the US, Europe, and China through eleven wholly-owned brand subsidiaries.
- Company typePublic
- Founded1901
- HeadquartersHolliston, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Harvard Bioscience does
Harvard Bioscience, Inc. (NASDAQ: HBIO) is a global developer, manufacturer, and marketer of specialized life science instruments and equipment used in preclinical research, founded in 1901 and headquartered in Holliston, Massachusetts. The company operates through a multi-brand platform of eleven wholly-owned subsidiaries — Biochrom, BTX, CMA, DSI (Data Sciences International), HEKA, Harvard Apparatus, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments — serving academic research institutions, pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and government laboratories across the United States, Europe, and China.
The product portfolio spans spectrophotometers, amino acid analyzers, patch clamp amplifiers, microelectrode array (MEA) systems, preclinical telemetry, electroporation and electrofusion instruments, microdialysis equipment, behavior research systems, syringe pumps, and physiology research tools. Notable first-in-class products include the SoHo implantable continuous glucose telemetry system (continuous monitoring in freely-moving animals), INCUB8 multiwell MEA (simultaneous optical and electrophysiological recording), and SmartUSSING Ussing chamber (sub-10-second automatic amplifier calibration). The software layer includes Ponemah, a GLP- and 21 CFR Part 11-compliant data acquisition and analysis platform supporting studies from hours to weeks, alongside technical services such as surgical support, data services, GLP validation, and training.
Revenue is generated through a mix of one-time capital equipment sales, higher-margin recurring consumables and reagents, subscription software licensing, and professional services. Distribution combines direct enterprise field sales, ten brand-specific e-commerce sites, and a new Fisher Scientific distribution agreement launched Q2 2026. Current strategic priorities include the Project Viking manufacturing consolidation (closing Holliston, MA in favor of Minneapolis plus European sites, targeting $4 million in annual savings), a cGMP-compliant BTX product launch into bioproduction in H2 2026, debt refinancing with BroadOak Capital Partners completed December 2025, and a 1-for-10 reverse stock split executed in March 2026 to regain Nasdaq compliance. FY2025 revenue was $86.6 million with gross margin near 60% and adjusted EBITDA of $3.8 million in Q4 2025, up 27% year-over-year.
Harvard Bioscience firmographics
Firmographics- Name
- Harvard Bioscience
- Legal name
- Harvard Bioscience Inc.
- Website
- https://harvardbioscience.com
- Company type
- Public
- Founded year
- 1901
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Harvard Bioscience is a global developer and manufacturer of specialized life science instruments for preclinical research, serving academic institutions, pharmaceutical companies, biotechnology firms, CROs, and government laboratories across the US, Europe, and China through eleven wholly-owned brand subsidiaries.
- Ownership category
- akta.pro rank
Harvard Bioscience industry classification
Industry- Product category
- Life Science Research Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industry
- Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)
Keywords
Where Harvard Bioscience is headquartered
LocationHeadquarters
- HQ city
- Holliston
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Harvard Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Life Science Instruments and Equipment: Sale of specialized instruments including spectrophotometers, amino acid analyzers, patch clamp amplifiers, microelectrode arrays, and telemetry systems for preclinical research.
- Consumables and Reagents: Higher-margin consumables including reagents, buffer kits, columns, and spare parts for instruments. Management targeting expansion into higher-margin consumables revenue.
- Software Licenses and Services: Software licensing including Ponemah software for data acquisition and analysis, with service packages including technical training and GLP validation services.
- Technical and Support Services: Service offerings including surgical services, data services, GLP validation services, and technical training services.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Harvard Bioscience product offering
Product offeringCore offering
Harvard Bioscience develops, manufactures, and markets a portfolio of specialized scientific instruments, apparatus, and consumables used in preclinical life science research. Its offerings span spectrophotometers, amino acid analyzers, patch clamp amplifiers, microelectrode array (MEA) systems, implantable telemetry, electroporation systems, and behavior research equipment sold under multiple acquired brands (Biochrom, BTX, DSI, HEKA, Harvard Apparatus, Multi Channel Systems, Panlab, Warner Instruments, Hugo Sachs Elektronik, KD Scientific, CMA) to academic, pharmaceutical, biotech, CRO, and government laboratory customers.
Product overview
Harvard Bioscience operates as a life science tools company with a multi-brand platform strategy. The company develops, manufactures, and markets specialized instruments for preclinical research across academic institutions, pharmaceutical companies, biotech firms, and contract research organizations. The product portfolio is organized around acquired brands including Biochrom (spectrophotometers, amino acid analyzers), DSI (implantable telemetry, Ponemah software), HEKA (patch clamp amplifiers), Multi Channel Systems (MEA systems, INCUB8), BTX (electroporation), Warner Instruments (Ussing chambers), Panlab (metabolic systems), Harvard Apparatus, Hugo Sachs Elektronik, KD Scientific (infusion pumps), and CMA (microdialysis). These brands serve three primary market applications: discovery (neuroscience, electrophysiology, cellular technologies), production/bioprocessing (amino acid analysis, spectrophotometry for quality control), and safety/regulatory compliance (GLP-compliant software, preclinical telemetry). The company also offers scientific services including surgical services, data services, GLP validation, and technical training to support its instrument portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- Biochrom: Spectrophotometers, colorimeters, and amino acid analyzers for life science research and quality control applications.
- BTX
- CMA
- DSI (Data Sciences International)
- HEKA
- Harvard Apparatus
- Hugo Sachs Elektronik
- KD Scientific
- Multi Channel Systems
- Panlab
- Warner Instruments
Products and services
- INCUB8 Multiwell MEA System First multiwell microelectrode array system offering simultaneous optical and electrophysiological data recording in a single instrument, enabling researchers to capture a more complete view of cellular events. Targeted at neuroscience, cellular electrophysiology, and organoid research customers.
- HEKA EPC 10 USB 3.0 Patch Clamp Amplifier
Quantifiable outcome
- Q4 2025 revenue of $23.7 million exceeding guidance with 60% gross margin at high end of guidance
- +3 more outcomes
Companies that use Harvard Bioscience
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles3 records
Harvard Bioscience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Harvard Bioscience partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Fisher ScientificmajorNew distribution agreement with Fisher Scientific expected to drive revenue starting Q2 2026. The partnership expands Harvard Bioscience's market reach through Fisher Scientific's extensive laboratory supply distribution network, supporting the company's growth initiatives targeting academic and pharmaceutical customers.
Scale indicators12 records
Recent moves9 records
Expansion highlights6 records
Harvard Bioscience competitors and assessment
Company assessmentDirect peers
- Axion Biosystems: Direct competitor in microelectrode array (MEA) systems for cellular electrophysiology, overlapping with Harvard Bioscience's Multi Channel Systems brand in the same academic and pharma research accounts.
- Molecular Devices (Danaher): Direct competitor in patch clamp amplifiers and electrophysiology instrumentation (Axopatch, MultiClamp), competing head-to-head with HEKA in academic neuroscience and ion channel research labs.
- TSE Systems: Direct competitor in preclinical telemetry and metabolic/behavior phenotyping, overlapping with DSI implantable telemetry and Panlab metabolic cages in CRO and academic preclinical research.
- emka TECHNOLOGIES: Direct competitor in preclinical telemetry, ECG, and respiratory monitoring for animal research, closely overlapping with DSI's telemetry product line in safety pharmacology studies.
- Sutter Instrument: Direct competitor in micropipette pullers, micromanipulators, and electrophysiology accessories used in patch clamp and single-cell recording workflows alongside HEKA equipment.
- Stoelting Co. Direct competitor in behavior research equipment including activity monitoring, learning/memory tests, and metabolic cages, overlapping with Panlab in neuroscience and behavioral pharmacology research.
Broad incumbents
- Bio-Rad Laboratories: Broader life science tools incumbent with electroporation systems (Gene Pulser) directly competing with BTX, plus broader cell biology and life science research products targeting overlapping pharma and academic customers.
Emerging players
- Standard BioTools (formerly Fluidigm): Smaller life science tools peer in mass cytometry and spatial biology with some MEA-adjacent cellular analysis; comparable in scale and similarly positioned in niche cell biology research markets.
- MaxWell Biosystems: Emerging high-density MEA player focused on single-cell and neuron-level electrophysiology, competing in the same cell biology and neuroscience research accounts as Multi Channel Systems.
- NPI Electronic: Specialized German manufacturer of electrophysiology amplifiers and signal processing equipment, competing with HEKA in single-channel and intracellular recording research applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Harvard Bioscience social profiles
Digital presenceHarvard Bioscience compliance and trust
Trust signalCompliance3 records
Harvard Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Harvard Bioscience leadership team
Management profileNumber of profiles
Profiles6 records
Harvard Bioscience subsidiaries and ownership
Company hierarchySubsidiaries11 records
Harvard Bioscience funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Harvard Bioscience M&A and investment
M&A and investmentM&A22 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Harvard Bioscience
What does Harvard Bioscience do?
Harvard Bioscience develops, manufactures, and markets a portfolio of specialized scientific instruments, apparatus, and consumables used in preclinical life science research. Its offerings span spectrophotometers, amino acid analyzers, patch clamp amplifiers, microelectrode array (MEA) systems, implantable telemetry, electroporation systems, and behavior research equipment sold under multiple acquired brands (Biochrom, BTX, DSI, HEKA, Harvard Apparatus, Multi Channel Systems, Panlab, Warner Instruments, Hugo Sachs Elektronik, KD Scientific, CMA) to academic, pharmaceutical, biotech, CRO, and government laboratory customers.
Is Harvard Bioscience a public or private company?
Harvard Bioscience is a public company. It is classified as public and is currently operating.
When was Harvard Bioscience founded?
Harvard Bioscience was founded in 1901. It employs 501 to 1,000 people.
Where is Harvard Bioscience based?
Harvard Bioscience is headquartered in Holliston, United States, in the North America region.
How does Harvard Bioscience make money?
Four revenue lines are on record. Life Science Instruments and Equipment is the primary driver. The others are consumables and Reagents, software Licenses and Services and technical and Support Services.
Who are Harvard Bioscience's main competitors?
Direct peers on record are Axion Biosystems, Molecular Devices (Danaher), TSE Systems, emka TECHNOLOGIES, Sutter Instrument and Stoelting Co.. Bio-Rad Laboratories is listed as a broad incumbent. Emerging players are Standard BioTools (formerly Fluidigm), MaxWell Biosystems and NPI Electronic.
Does Harvard Bioscience have an API?
No public API is recorded for Harvard Bioscience.
What industry is Harvard Bioscience in?
Harvard Bioscience's product category is Life Science Research Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.